5 results on '"Emily Hayes"'
Search Results
2. Team-based versus technology-based supportive cancer care (SCC): Implementation across 24 clinical settings.
- Author
-
Moufarrej, Sacha, primary, Wood, Emily Hayes, additional, Medrano, Hector S., additional, Perez, Cynthia, additional, Agrawal, Madhuri, additional, and Patel, Manali I., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Addressing Latinx cancer care equity program for long-term united skills building (ALCANCE-PLUS): Updated results from an ongoing implementation.
- Author
-
Wood, Emily Hayes, Kamran, Rafaay, Lopez Guzman, Lesly, Reynaga, Jajaira, Villicana, Gerardo, Valdez-Garcia, Jasmine, Hanna, Maria, Trotter, Chardria, Koontz, Zachary M., and Patel, Manali I.
- Subjects
HEALTH services accessibility ,HUMAN services programs ,HISPANIC Americans ,CANCER patient medical care ,EVALUATION of human services programs ,CONFERENCES & conventions - Abstract
151 Background: Addressing Latinx Cancer Care Equity - Program for Long-term United Skills Building (ALCANCE-PLUS) is an ongoing community-academic partnership between the Stanford University School of Medicine Partnerships to Advance Care and Pacific Cancer Care (PCC). The partnership began in 2019 and is comprised of several community-identified multi-level interventions to improve cancer health equity in an undeserved, rural migrant farm-working community. The intervention components are delivered by trained community health workers to low-income and racial and ethnic minoritized patients receiving active cancer treatment and include: 1) precision medicine education using literacy- and language-concordant educational tools; 2) food insecurity screening and intervention with plans to cross-train > 150 CHW's across the county to expand cancer screening and care delivery in the county. Here, we describe the characteristics of participants and the program's impact to date on metrics identified by the community. Methods: ALCANCE-PLUS eligibility includes: all patients with cancer actively receiving cancer-directed treatment at PCC who are ≥ 18 years old and speak English or Spanish. Community identified metrics of success include: % treatment adherence (completion), no-show rate, days from diagnosis to treatment, and % who received clinical trials education as compared to baseline (prior to program start). We used descriptive statistics and chi-squared tests to compare metrics of participants in the program to baseline. Results: At baseline, 62% of low-income and racial and ethnic minoritized patients in the county completed treatment, 35% had no-shows to clinic or infusion appointments with an average of 82.7 days from diagnosis to treatment and only 15% received clinical trial education. From July 2022 to May 2024, a total of 164 patients participated in the program. Mean ages were 60.88 ± 14.55, 68 (41.5%) identified as male, 104 (63.4%) as Hispanic or Latino, 2 (1.2%) African American or Black, 12 (7.3%) Asian American, 2 (1.2%) Native Hawaiian or Other Pacific Islanders, and 60 (36.6%) White. Insurance types included 63 (25.6%) patients with Medicaid, 56 (22.6) with Medicare, 13 (5.2%) with both, 72 (29%) with private insurance, and 7 (2.8%) with other insurance or uninsured. As of January 2024, treatment adherence was 100% for the 157 program participants, the average time from diagnosis to treatment dropped from 82.7 days county-wide pre-program to 30 days among enrolled participants, all participants received clinical trial education, and 38 (24.2%) were actively participating in a clinical trial. Conclusions: Community-academic partnerships to co-design and implement approaches to overcome community-identified needs for marginalized populations are essential to achieve cancer health equity. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Food for Cancer Health Equity: The impact of a culturally tailored food voucher intervention on food insecurity among Latinx patients with cancer.
- Author
-
Hanna, Maria, Wood, Emily Hayes, Villicana, Gerardo, Lopez Guzman, Lesly, Escobar, Kasandra, Reynaga, Jajaira, Trotter, Chardria, Koontz, Zachary M., Seligman, Hilary K., and Patel, Manali I.
- Subjects
FOOD security ,CLINICAL trials ,CONFERENCES & conventions ,QUALITY of life ,TUMORS - Abstract
182 Background: Food insecurity disproportionately impacts immigrant, low-income, and racial and ethnic minorities with cancer. In our prior qualitative work, Latinx and multiethnic patients with food insecurity emphasized the importance of culturally-tailored food assistance interventions that could minimize stigma and maintain self-efficacy and autonomy. In collaboration with Latinx patients and community partners in Monterey County, California, we co-developed a culturally-tailored food voucher intervention. In this study, we conducted a pilot of the intervention among multiethnic and Latinx patients with cancer and tested the impact on food insecurity and health-related quality of life. Methods: We recruited low-income, racial and ethnic minority adults > 18 years of age who screened positive for food insecurity using the 2-item Hunger Vital Sign while receiving cancer treatment in a clinic in Monterey County, CA between July 2023 until August 2023. All participants who consented to participate received $40 monthly grocery store gift cards redeemable at a variety of local retailers for 6 months in addition to usual care provided by trained community health workers who assisted with other health-related social needs. We conducted validated surveys at baseline (time of enrollment) and 6-month follow-up (post-intervention) assessing demographics, food behaviors, food insecurity, and health-related quality of life, as well as feasibility and acceptability of the intervention. We compared pre- and post-intervention proportions with food insecurity using McNemars tests and change in health-related quality of life using paired t-tests. Results: Of the 30 study participants enrolled, 27 (90%) were Latinx; 24 (80%) spoke Spanish as their preferred language; 16 (53%) had advanced (stage 3 or 4) cancer; 12 (40%) were retired or unemployed; 10 (33%) were disabled; 20 (67%) reported a household income < $35,000 USD. Of the 26 (87%) participants who completed post-intervention surveys, the proportion with food insecurity decreased from 100% to 65% (95% CI 0.60-0.77; p = 0.01); 100% adhered to recommended treatment; and health-related quality of life scores increased by 8 points from 71.9 +/-16.1 to 79.5+/- 10.5 (p = 0.02) from baseline. All (100%) participants rated the program as feasible and acceptable in post-intervention surveys. Conclusions: This culturally-tailored food voucher intervention was associated with reductions in food insecurity and improvements in health-related quality of life among low-income Latinx patients with cancer. This intervention may represent an effective and acceptable approach to overcome food insecurity in Latinx and multiethnic patients with cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. A community health worker–led intervention to improve patient knowledge and receipt of precision medicine: Updated ALCANCE randomized clinical trial findings.
- Author
-
Wood, Emily Hayes, Rodriguez, Gladys M., Villicana, Gerardo, Lopez Guzman, Lesly, Reynaga, Jajaira, Trotter, Chardria, Koontz, Zachary M., and Patel, Manali I.
- Subjects
HEALTH literacy ,STATISTICAL sampling ,CONFERENCES & conventions ,RANDOMIZED controlled trials ,HEALTH promotion ,ACCURACY ,INDIVIDUALIZED medicine ,PATIENTS' attitudes - Abstract
181 Background: Inequitable access to precision medicine limits its impact. To address disparities, we co-developed the Addressing Latinx Cancer Care Equity Study (NCT04843332), a multi-level intervention with community stakeholders. ALCANCE was designed for low-income and Latinx adults with cancer in rural Monterey County, California. We provided annual training for clinicians about testing guidelines and precision medicine disparities. Trained CHWs educated patients about precision medicine and encouraged them to raise the topic with their oncologist. We tested whether the intervention improved patient knowledge and receipt of precision medicine. Methods: Patients with newly diagnosed or recurrent cancer, age ≥ 18 years, able to consent in English or Spanish, and who self-identified as a racial and ethnic minority OR low-income status OR were insured by public or agricultural company insurance OR uninsured and receiving cancer care at Pacific Cancer Care, a rural community oncology practice in Monterey County, were randomized 1:1 to usual care (control group) or usual care augmented with the multi-level intervention for 12 months (intervention group). The primary outcome was whether the multilevel intervention could increase patient knowledge of precision medicine using a validated 6 question survey from time of enrollment (baseline) to 6-months post-enrollment between groups. A secondary outcome was receipt of precision medicine. CHWs and clinicians completed semi-structured interviews. Results: 110 participants were randomized; 70% (n = 67) reported Spanish as their primary language; 81% (n = 89) identified as Hispanic. Median age was 55 years (55.4 ± 14.3, mean± SD); majority had annual household incomes (USD) ≤ $34,999 (59.0%, n = 46); majority obtained a high school diploma/GED or less (67.3%, n = 74). Most had gastrointestinal (35.5%, n = 39) and breast (24.5%, n = 27) cancers and were diagnosed with stage 3 or 4 (64.5%, n = 71) disease. Precision medicine knowledge was low at baseline across both the control and intervention groups (23.5 ± 19.3 versus 23.0 ± 17.7, respectively). Intervention group participants had greater precision medicine knowledge at 6-months (39.2 ± 23.0) than control group participants (24.2 ± 20.0) with greater increase in knowledge overtime than control group participants (p < 0.001). More intervention group participants (n=46, 79.3%) received precision medicine testing than control (n=34, 60.7%). Across both groups, 26 of those tested had an actionable mutation. Of those 26, 66.7% (n=6 of 9) in the control group and 94.1% (n=16 of 17) in the intervention group received targeted therapy (p=0.065). Interviews with the care team indicated the model was acceptable and has been sustained as part of usual care. Conclusions: CHW-facilitated interventions may reduce disparities in precision medicine cancer care. Clinical trial information: NCT04843332 [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.